These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


392 related items for PubMed ID: 8645026

  • 1. [The development of a new QOL Questionnaire on chemotherapy - induced emesis and vomiting--investigation of reliability and validity. Group for Investigation of QOL Questionnaire for Anti-Emetics Used in Cancer Chemotherapy. Joint Research Group for Tropisetron Double-Blind Comparative study].
    Ishihara Y, Nukariya N, Kobayashi K, Yoneda S, Matsuda T, Yakushiji M, Yamakido M, Fukuoka M, Niitani H, Furue H.
    Gan To Kagaku Ryoho; 1996 May; 23(6):745-55. PubMed ID: 8645026
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A novel prospective descriptive analysis of nausea and vomiting among patients receiving gastrointestinal radiation therapy.
    Poon M, Hwang J, Dennis K, DeAngelis C, Zhang L, Chung H, Stinson J, Wong S, Pulenzas N, Chow E.
    Support Care Cancer; 2016 Apr; 24(4):1545-61. PubMed ID: 26377308
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial.
    Pérol D, Provençal J, Hardy-Bessard AC, Coeffic D, Jacquin JP, Agostini C, Bachelot T, Guastalla JP, Pivot X, Martin JP, Bajard A, Ray-Coquard I.
    BMC Cancer; 2012 Dec 17; 12():603. PubMed ID: 23244208
    [Abstract] [Full Text] [Related]

  • 15. Quality of life consequences of chemotherapy-induced emesis.
    Lindley CM, Hirsch JD, O'Neill CV, Transau MC, Gilbert CS, Osterhaus JT.
    Qual Life Res; 1992 Oct 17; 1(5):331-40. PubMed ID: 1299465
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Optimal combination therapy with tropisetron in 445 patients with incomplete control of chemotherapy-induced nausea and vomiting.
    Hulstaert F, Van Belle S, Bleiberg H, Canon JL, Dewitte M, Buyse M, De Keyser P, Westelinck KJ.
    J Clin Oncol; 1994 Nov 17; 12(11):2439-46. PubMed ID: 7964961
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mail-in questionnaire for monitoring nausea and vomiting in oncology outpatients.
    Mullin SM, Fletcher DM, Tyler LS.
    Am J Health Syst Pharm; 1998 Sep 15; 55(18):1903-6. PubMed ID: 9784770
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.